The computer vision technology provider has secured $30m in a GV-led round that included NGP Capital, bringing its total funding to $43m.

Athyrium Capital Management provided the capital for Debiopharm and Axa-backed breast cancer diagnostics system developer Agendia.

Biopharmaceutical company Liquidia Technologies, which counts PPD and Siemens as investors, floated in the middle of its range.

IP Group recorded a $24m loss in a period when the firm also restructured its business following the acquisition of Touchstone Innovations.

The UPMC Enterprises-backed mental health tool provider had raised more than $21m but is shuttering after failing to secure an acquisition.

NetEase has provided $50m for game development software producer Improbable in a deal that reportedly doubled its valuation to $2bn.

The UPMC Enterprises-backed mental health tool provider had raised more than $21m but is shuttering after failing to secure an acquisition.

Merck & Co, Celgene, Amgen and Eli Lilly all took part in an $85.4m round that boosted the cancer drug developer's total funding to more than $175m.

The decentralised IoT security platform developer has raised series A funding from investors including General Electric's GE Ventures unit.

Online lending processor PaySense has raised money in a series B round led by an $11.5m investment from strategic backer PayU.